Ex Parte JOB - Page 3



          Appeal No. 2001-2509                                                        
          Application No. 08/603,331                                                  

               Appealed claims 24-28, 32, 38, 39 and 45 stand rejected                
          under 35 U.S.C. § 102 as being anticipated by Ballantyne.  Claims           
          30 and 31 stand rejected under 35 U.S.C. § 103 as being                     
          unpatentable over Ballantyne.  Claim 37 stands rejected under               
          35 U.S.C. § 103 as being unpatentable over Ballantyne in view of            
          Tupper.  In addition, claims 24, 25, 31 and 45 stand rejected               
          under 35 U.S.C. § 102 as being anticipated by Loos.  Also, claims           
          24, 25, 27, 28, 31, 32, 38 and 45 stand rejected under 35 U.S.C.            
          § 102 as being anticipated by Priore.                                       
               Appellant submits at page 6 of the principal brief that                
          claims 24, 26-28, 31, 32 and 39 stand or fall together, as do               
          claims 25 and 38.  Also, appellant states that claims 30, 37 and            
          45 are to be considered independently.                                      
               We have thoroughly reviewed each of appellant’s arguments              
          for patentability.  However we are in substantial agreement with            
          the examiner’s application of the prior art and disposition of              
          the arguments raised by appellant.  Accordingly, inasmuch as we             
          find that the examiner’s rejections are free of reversible error,           
          they will be sustained.                                                     
               We consider first the examiner’s rejection of claims 24-28,            
          32, 38, 39 and 45 under § 102 over Ballantyne.  The principal               

                                          3                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007